
Latest headlines
Abbott News
The latest Abbott (ABT) news, aggregated as it breaks. News moves sentiment and sentiment moves price, so read these ABT headlines next to the live Abbott Fear and Greed Index.
Latest Abbott Headlines36

Abbott's next-generation Amulet 360™ device receives CE Mark to treat people with atrial fibrillation at risk of stroke
prnewswire.com · Aug 27, 2026

FDA authorizes Abbott's wearable to monitor ketone and glucose in diabetes patients
reuters.com · Aug 25, 2026

Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes
gurufocus.com · Aug 25, 2026

Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes
prnewswire.com · Aug 25, 2026

Abbott vs. DexCom: Which CGM Stock Is the Better Buy Now?
zacks.com · Aug 25, 2026

NVST or ABT: Which Is the Better Value Stock Right Now?
zacks.com · Aug 24, 2026

Here's What Is Shaping Abbott's Diagnostics Growth
zacks.com · Aug 24, 2026

Billionaire Ken Griffin Just Loaded Up on AbbVie and Abbott. Here's Whether Investors Should Follow His Lead.
fool.com · Aug 24, 2026

ABT DCF Analysis: Intrinsic Value $94 vs Price $117
gurufocus.com · Aug 24, 2026

Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson?
fool.com · Aug 23, 2026

Abbott agrees to $670 million settlement of infant formula cases
reuters.com · Aug 20, 2026

Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas for preterm infants
prnewswire.com · Aug 20, 2026

Here's How Abbott's Medical Devices Arm Acts as a Growth Catalyst
zacks.com · Aug 19, 2026

Abbott Laboratories: Diagnostics And Medical Devices Fuel Next Growth Phase (Downgrade)
seekingalpha.com · Aug 19, 2026

Abbott Laboratories: Reasonably Valued After Surge, But Still An Attractive Buy Long-Term
seekingalpha.com · Aug 19, 2026

Abbott and NACHC launch nationwide Food for Health initiative to make nutritious food a core part of healthcare
gurufocus.com · Aug 17, 2026

Abbott and NACHC launch nationwide Food for Health initiative to make nutritious food a core part of healthcare
prnewswire.com · Aug 17, 2026

ABT DCF Analysis: Intrinsic Value $94 vs Price $111
gurufocus.com · Aug 17, 2026

How To Invest $100,000 In A Retiree's SWAN Income Portfolio
seekingalpha.com · Aug 15, 2026

What's Backing Abbott's Established Pharmaceuticals Division Growth
zacks.com · Aug 13, 2026

Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis
prnewswire.com · Aug 12, 2026

The U.S. Labor Market Is Weakening. These 2 Dividend Stocks Look Built to Weather a Recession
fool.com · Aug 11, 2026

Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI
prnewswire.com · Aug 11, 2026

Should You Buy, Hold or Sell ABT Stock Amid Medical Devices Boom?
zacks.com · Aug 10, 2026

AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026?
fool.com · Aug 7, 2026

NVST vs. ABT: Which Stock Is the Better Value Option?
zacks.com · Aug 7, 2026

Here's How ABT Broadens Diagnostics Growth Base With Oncology Expansion
zacks.com · Aug 7, 2026

Abbott Laboratories vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?
fool.com · Aug 2, 2026

Abbott Laboratories vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?
fool.com · Jul 31, 2026

3 Dividend Stocks to Buy for a Lifetime of Passive Income
fool.com · Jul 29, 2026

These 3 Companies Reported Record Results and Raised Guidance
zacks.com · Jul 28, 2026

Abbott Rides Key Diabetes, Oncology and Heart Care Innovation Trends
zacks.com · Jul 28, 2026

Is Abbott Stock Attractive After Its Earnings and Guidance Update?
zacks.com · Jul 27, 2026

FDA Approves Freenome's SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
globenewswire.com · Jul 27, 2026

Q2 Earnings: Guidance Upgrades Push These 3 Stocks Higher
zacks.com · Jul 24, 2026

ISRG vs. ABT: Which MedTech Giant Is the Smarter Investment Now?
zacks.com · Jul 23, 2026
Why Is Abbott Up or Down Today?
When Abbott (ABT) moves sharply, the reason is almost always in the headlines above. Earnings, guidance, analyst upgrades and downgrades, product news and macro data are the usual drivers of a ABT move on the day. The feed shows what broke and when, and the sentiment tag on each story shows whether the coverage skews positive or negative, so you can see at a glance why Abbott is up or down today.
How Abbott News Affects the Price
News does not move the Abbott (ABT) price directly, it moves sentiment, and sentiment moves price. A run of negative headlines pulls the Abbott Fear and Greed Index toward fear, while positive coverage pushes it toward greed, often before the price has fully reacted. A surprise story usually shows up first as a spike in Abbott trading volume. That is the chain to watch: headline, sentiment, volume, then the ABT price.
Trade the Abbott News With Sentiment
Headlines tell you what happened; the Fear and Greed Index tells you how the crowd is reacting. Watch Abbott trading volume spike on a big story, check the Abbott price history for context, follow the live ABT price, see the Abbott price prediction, and read the Abbott Fear and Greed Index for mood.
How do you feel about Abbott?
1DFrequently asked questions
Why is Abbott up or down today?
What is the latest Abbott news?
Where does Abbott news come from?
How often is Abbott news updated?
How does Abbott news relate to its Fear and Greed Index?
Headlines are aggregated from third-party sources and link to the original publishers. CFGI does not author or endorse them.
About CFGI
The per-asset sentiment record.
CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.
Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.